{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:30:06Z","timestamp":1792445406259,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.breast.2024.103786","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T07:20:23Z","timestamp":1723188023000},"page":"103786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Non-invasive prediction of axillary lymph node dissection exemption in breast cancer patients post-neoadjuvant therapy: A radiomics and deep learning analysis on longitudinal DCE-MRI data"],"prefix":"10.1016","volume":"77","author":[{"given":"Yushuai","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2024.103786_bib1","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1200\/JCO.2005.02.5023","article-title":"Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy","volume":"23","author":"Hennessy","year":"2005","journal-title":"J Clin Oncol : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.breast.2024.103786_bib2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/cncr.21726","article-title":"Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy","volume":"106","author":"Hennessy","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2024.103786_bib3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gradishar","year":"2022","journal-title":"J Natl Compr Cancer Netw : J Natl Compr Cancer Netw"},{"key":"10.1016\/j.breast.2024.103786_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.21388","article-title":"Trends in disparities and transitions of treatment in patients with early breast cancer in China and the US, 2011 to 2021","volume":"6","author":"Li","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.breast.2024.103786_bib5","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1245\/s10434-015-5052-8","article-title":"Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodes","volume":"23","author":"Diego","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2024.103786_bib6","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2024.103786_bib7","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Annals of surgery"},{"key":"10.1016\/j.breast.2024.103786_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.breast.2007.08.006","article-title":"Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group","volume":"17","author":"Husted Madsen","year":"2008","journal-title":"Breast"},{"key":"10.1016\/j.breast.2024.103786_bib9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejso.2007.05.017","article-title":"Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial","volume":"34","author":"Del Bianco","year":"2008","journal-title":"Eur J Surg Oncol : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"key":"10.1016\/j.breast.2024.103786_bib10","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and Resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Annals of surgery"},{"key":"10.1016\/j.breast.2024.103786_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2024.103786_bib12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.breast.2024.103786_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.clbc.2019.01.013","article-title":"Axillary lymph node tattooing and targeted axillary dissection in breast cancer patients who presented as cN+ before neoadjuvant chemotherapy and became cN0 after treatment","volume":"19","author":"Natsiopoulos","year":"2019","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2024.103786_bib14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Annals of surgery"},{"key":"10.1016\/j.breast.2024.103786_bib15","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/S1470-2045(13)70590-4","article-title":"Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review","volume":"15","author":"Ahmed","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2024.103786_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1053\/j.semnuclmed.2022.01.006","article-title":"Sentinel lymph node methods in breast cancer","volume":"52","author":"Giammarile","year":"2022","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.breast.2024.103786_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejrad.2014.09.020","article-title":"Noninvasive nodal restaging in clinically node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review","volume":"84","author":"Schipper","year":"2015","journal-title":"European journal of radiology"},{"key":"10.1016\/j.breast.2024.103786_bib18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1148\/radiol.2017162333","article-title":"Qualitative radiogenomics: association between oncotype DX test recurrence score and BI-rads mammographic and breast MR imaging features","volume":"286","author":"Woodard","year":"2018","journal-title":"Radiology"},{"issue":"Suppl 1","key":"10.1016\/j.breast.2024.103786_bib19","article-title":"MRI radiomics for assessment of molecular subtype, pathological complete response, and residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy","volume":"29","author":"Choudhery","year":"2022","journal-title":"Acad Radiol"},{"key":"10.1016\/j.breast.2024.103786_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12967-023-04201-8","article-title":"Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound","volume":"21","author":"Zhang","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.breast.2024.103786_bib21","doi-asserted-by":"crossref","first-page":"7685","DOI":"10.1245\/s10434-022-12034-w","article-title":"A noninvasive tool based on magnetic resonance imaging radiomics for the preoperative prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer","volume":"29","author":"Li","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2024.103786_bib22","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1093\/oncolo\/oyad010","article-title":"CT radiomics for predicting pathological complete response of axillary lymph nodes in breast cancer after neoadjuvant chemotherapy: a prospective study","volume":"28","author":"Li","year":"2023","journal-title":"Oncol"},{"key":"10.1016\/j.breast.2024.103786_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101562","article-title":"Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: a multicentre, retrospective cohort study","volume":"52","author":"Liu","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.breast.2024.103786_bib24","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/modpathol.2015.74","article-title":"Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group","volume":"28","author":"Provenzano","year":"2015","journal-title":"Mod Pathol : an official journal of the United States and Canadian Academy of Pathology, Inc."},{"key":"10.1016\/j.breast.2024.103786_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.chaos.2021.110749","article-title":"Using handpicked features in conjunction with ResNet-50 for improved detection of COVID-19 from chest X-ray images","volume":"145","author":"Rajpal","year":"2021","journal-title":"Chaos, Solit Fractals"},{"key":"10.1016\/j.breast.2024.103786_bib26","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/bjs.10244","article-title":"Overfitting","volume":"103","author":"Cook","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.breast.2024.103786_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103460","article-title":"Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: a machine learning, multicenter study","volume":"69","author":"Yu","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.breast.2024.103786_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.541849","article-title":"Radiomics nomogram of DCE-MRI for the prediction of axillary lymph node metastasis in breast cancer","volume":"10","author":"Mao","year":"2020","journal-title":"Frontiers in oncology"},{"key":"10.1016\/j.breast.2024.103786_bib29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.stem.2015.08.014","article-title":"Therapeutic implications of cellular heterogeneity and plasticity in breast cancer","volume":"17","author":"Brooks","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.breast.2024.103786_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108253","article-title":"Triple negative breast cancer (TNBC): non-genetic tumor heterogeneity and immune microenvironment: emerging treatment options","volume":"237","author":"So","year":"2022","journal-title":"Pharmacology & therapeutics"},{"key":"10.1016\/j.breast.2024.103786_bib31","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djz208","article-title":"Unraveling triple-negative breast cancer tumor microenvironment heterogeneity: towards an optimized treatment approach","volume":"112","author":"Bareche","year":"2020","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.breast.2024.103786_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13058-022-01516-0","article-title":"Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment","volume":"24","author":"Wang","year":"2022","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2024.103786_bib33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41467-019-08593-4","article-title":"Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy","volume":"10","author":"Caswell-Jin","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.breast.2024.103786_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1148\/radiol.14130569","article-title":"Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapy","volume":"272","author":"Parikh","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.breast.2024.103786_bib35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13073-018-0601-y","article-title":"Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations","volume":"10","author":"H\u00f6glander","year":"2018","journal-title":"Genome Med"},{"key":"10.1016\/j.breast.2024.103786_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00994018","article-title":"Support vector networks","volume":"20","author":"Cortes","year":"1995","journal-title":"Mach Learn"},{"key":"10.1016\/j.breast.2024.103786_bib37","first-page":"5560","article-title":"Sparse SVM for sufficient data reduction","volume":"44","author":"Zhou","year":"2022","journal-title":"IEEE Trans Pattern Anal Mach Intell"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977624001176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977624001176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T01:33:00Z","timestamp":1726104780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977624001176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":37,"alternative-id":["S0960977624001176"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2024.103786","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-invasive prediction of axillary lymph node dissection exemption in breast cancer patients post-neoadjuvant therapy: A radiomics and deep learning analysis on longitudinal DCE-MRI data","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2024.103786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103786"}}